These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4317688)

  • 21. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new animal model of Bordetella pertussis infection and immunity.
    Foreman-Wykert AK; Miller JF
    Trends Microbiol; 2005 Dec; 13(12):559-60. PubMed ID: 16223585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica on tissue cultures].
    Schubarth H
    Arch Hyg Bakteriol; 1966 Sep; 150(5):468-76. PubMed ID: 4295633
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the immunizing capacity of orally administered particulate antigens. I. The efficiency of killed Bordetella pertussis cells.
    Hof H; Finger H; Körner L; Milcke L
    Zentralbl Bakteriol Orig A; 1975; 230(2):210-22. PubMed ID: 167535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The coleukemogenic action of Bordetella pertussis].
    Shevliagin VIa; Shaposhnikova GM; Snegireva AE; Mertsalova NU
    Eksp Onkol; 1989; 11(4):50-2. PubMed ID: 2547574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure and biological activity of Bordetella pertussis endotoxin (proceedings)].
    Finger H; Heymer B; Hof H; Rietschel E; Schleifer KH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):56-64. PubMed ID: 185848
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Accumulation of the bvg- Bordetella pertussis a virulent mutants in the process of experimental whooping cough in mice].
    Medkova AIu; Siniashina LN; Rumiantseva IuP; Voronina OL; Kunda MS; Karataev GI
    Mol Gen Mikrobiol Virusol; 2013; (4):22-6. PubMed ID: 24645274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delayed brain injury induced by Bordetella pertussis in rats].
    Chen X; Yang Y; Tao Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):301-3. PubMed ID: 9868080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease.
    Carbonetti NH
    Curr Opin Pharmacol; 2007 Jun; 7(3):272-8. PubMed ID: 17418639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological and histological reactions to respiratory administration of ribosomal Bordetella pertussis vaccine in mice.
    Bartlema HC; Braunius R
    Z Erkr Atmungsorgane; 1979 May; 153(2):254-60. PubMed ID: 232799
    [No Abstract]   [Full Text] [Related]  

  • 35. [Encephalitogenic activity of Bordetella pertussis].
    Kantchourine AK; Kapitonova ME
    Ann Inst Pasteur (Paris); 1969 Sep; 117(3):378-82. PubMed ID: 4312603
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental infection of mice by Fonsecaea pedrosoi and Wangiella dermatitidis.
    Polak A
    Sabouraudia; 1984; 22(2):167-9. PubMed ID: 6539507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of vitamin A and zinc on wound healing in steroid-treated mice.
    Trevisani MF; Ricci MA; Tolland JT; Beck WC
    Curr Surg; 1987; 44(5):390-3. PubMed ID: 3691171
    [No Abstract]   [Full Text] [Related]  

  • 38. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
    Fennelly NK; Sisti F; Higgins SC; Ross PJ; van der Heide H; Mooi FR; Boyd A; Mills KH
    Infect Immun; 2008 Mar; 76(3):1257-66. PubMed ID: 18195025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of extracts of Hemophilus pertussis on leukocyte counts in normal and sensitized mice.
    BRADFORD WL; SCHERP HW; TINKER MR
    Pediatrics; 1956 Jul; 18(1):64-71. PubMed ID: 13335322
    [No Abstract]   [Full Text] [Related]  

  • 40. Virulence of a Bordetella pertussis strain expressing a mutant adenylyl cyclase with decreased calmodulin affinity.
    Oldenburg DJ; Gross MK; Smith AL; Storm DR
    Microb Pathog; 1993 Jun; 14(6):489-93. PubMed ID: 8412621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.